Profile
Sector:
HealthcareIndustry:
Drug Manufacturers - GeneralCountry:
United KingdomIPO:
12 May 1993Website:
http://www.astrazeneca.comNext earnings report:
12 November 2024Last dividends:
09 August 2024Next dividends:
N/APrice
after hours | 9 min agoAnalysts recommendations
Institutional Ownership
AZN Latest News
In the most recent trading session, Astrazeneca (AZN) closed at $71.42, indicating a +0.38% shift from the previous trading day.
AstraZeneca PLC (LSE:AZN) has confirmed that the president of its China division has been placed under investigation by local police as part of an anti-corruption drive. Leon Wang, who forms part of its senior executive team, is cooperating with an investigation by Chinese authorities said a statement yesterday from the pharma group released during the Budget speech without giving further details.
AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating with Chinese authorities.
Astrazeneca (AZN) closed the most recent trading day at $75.05, moving -1.12% from the previous trading session.
ECC5004/AZD5004 is an investigational oral small molecule GLP-1 receptor agonist licensed to AstraZeneca in November 2023 ECC5004/AZD5004 is an investigational oral small molecule GLP-1 receptor agonist licensed to AstraZeneca in November 2023
The CHMP recommends approval for AZN's Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Astrazeneca (AZN) and Novo Nordisk (NVO). But which of these two stocks offers value investors a better bang for their buck right now?
Astrazeneca (AZN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
AZN inks an agreement with CSPC Pharmaceutical to develop a novel lipid-lowering therapy targeting various cardiovascular diseases.
AstraZeneca has entered into an exclusive licensing agreement with CSPC Pharmaceutical Group to advance the development of a novel preclinical small molecule lipoprotein(a) (Lp(a)) inhibitor.
What type of business is AstraZeneca?
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
What sector is AstraZeneca in?
AstraZeneca is in the Healthcare sector
What industry is AstraZeneca in?
AstraZeneca is in the Drug Manufacturers - General industry
What country is AstraZeneca from?
AstraZeneca is headquartered in United Kingdom
When did AstraZeneca go public?
AstraZeneca initial public offering (IPO) was on 12 May 1993
What is AstraZeneca website?
https://www.astrazeneca.com
Is AstraZeneca in the S&P 500?
No, AstraZeneca is not included in the S&P 500 index
Is AstraZeneca in the NASDAQ 100?
Yes, AstraZeneca is included in the NASDAQ 100 index
Is AstraZeneca in the Dow Jones?
No, AstraZeneca is not included in the Dow Jones index
When was AstraZeneca the previous earnings report?
No data
When does AstraZeneca earnings report?
The next expected earnings date for AstraZeneca is 12 November 2024